Teva Respiratory has high-quality, cost-effective treatment options uniquely designed for people with a wide range of respiratory conditions and allergy symptoms. In addition, Teva Respiratory is expanding into other respiratory therapy areas where unmet need exists.
The portfolio is centered on optimizing respiratory therapies for patients through novel delivery systems and therapies that address unmet needs. In the US, Teva Respiratory currently ranks second among branded respiratory companies based on number of prescriptions dispensed.
In recent years, we have continued to build upon our experience in the development, manufacture and commercialization of inhaled respiratory medicines primarily for asthma, COPD, and allergic rhinitis.